Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Condition:   T Lymphoblastic Leukemia/Lymphoma Intervention:   Drug: Chidamide Sponsor:   Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials